Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic
Stat Biopharm Res
.
2020 Oct 28;12(4):397-398.
doi: 10.1080/19466315.2020.1828692.
Authors
Toshimitsu Hamasaki
1
,
Frank Bretz
2
3
,
Freda Cooner
4
,
Lisa M LaVange
5
,
Martin Posch
3
Affiliations
1
The George Washington University Biostatistics Center, Rockville, MD.
2
Clinical Development & Analytics, Novartis Pharma, Basel, Switzerland.
3
Section for Medical Statistics, Medical University of Vienna, Vienna, Austria.
4
Statistical Innovation, Amgen, Thousand Oaks, CA.
5
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
PMID:
34191970
PMCID:
PMC8011482
DOI:
10.1080/19466315.2020.1828692
No abstract available
Publication types
Editorial